Pediatric Hepatology - Clinical
Nov
12
2023
Room 304/306
-
Hynes Convention Center
2:00
- 3:30 PM EST
Speakers
Description
The diagnosis and management of childhood liver disorders are undergoing rapid changes, aided by novel investigative approaches. In this session, attendees will learn from state-of-the-art clinical and translational studies advancing the field of pediatric hepatology.
Abstracts
- A PILOT STUDY OF MULTIPLEXED PROTEOMIC NEWBORN SCREENING FOR WILSON DISEASE IN WA STATE
- THE SIGNIFICANT ASSOCIATION BETWEEN PNPLA3 G ALLELE AND ADVANCED FIBROSIS IN CHILDREN WITH NAFLD IS FURTHER INFLUENCED BY BMI AND type2 DIABETES
- A-LINK: UTILIZING A LEARNING HEALTH NETWORK MODEL FOR IMPROVING OUTCOMES IN AUTOIMMUNE HEPATITIS
- SERUM BILE ACIDS ARE ASSOCIATED WITH NATIVE LIVER SURVIVAL IN PATIENTS WITH ALAGILLE SYNDROME: RESULTS FROM THE GALA STUDY GROUP
- SPLEEN STIFFNESS MEASUREMENT BY TRANSIENT ELASTOGRAPHY WITH A SPLEEN-DEDICATED MODULE: A PROSPECTIVE PILOT FEASIBILITY STUDY IN A PEDIATRIC COHORT
- INDIVIDUAL PRURITUS AND BILE ACID RESPONSES OVER TIME WITH ODEVIXIBAT TREATMENT: POOLED DATA FROM THE PHASE 3 ASSERT AND ASSERT-EXT STUDIES IN PATIENTS WITH ALAGILLE SYNDROME
Objectives
- Attendees will review and discuss advances in diagnosing childhood liver disorders.
- Session attendees will learn from multi-center studies and clinical trials regarding the management of pediatric autoimmune and cholestatic disorders.
- Describe feasibility of screening testing in liver disorders.